From February 25-26, 2026, a transformative initiative took shape in Kigali that could fundamentally alter East Africa's relationship with global health supply chains and pandemic preparedness. Leaders from government, academia, industry, and development partners gathered for the inaugural Regional Capability and Capacity Network (RCCN) – East Africa Conference of Partners Workshop, an Africa CDC-led initiative designed to strengthen workforce capabilities and expand local vaccine and health product manufacturing across five countries: Rwanda, Tanzania, Uganda, Kenya, and Ethiopia. The establishment of the RCCN East Africa Secretariat in Kigali, hosted by Rwanda through Syllabi under the Ministry of Education, represents more than an administrative arrangement — it signals a strategic regional commitment to building the human capital, institutional frameworks, and collaborative ecosystems necessary to transform East Africa from a consumer of imported health products to a producer capable of meeting its own needs and competing globally. This article examines why the COVID-19 pandemic exposed critical vulnerabilities in Africa's health security architecture, how the RCCN is designed to address these gaps through coordinated workforce development and regional collaboration, what role Rwanda is playing in anchoring this transformation, and what success would mean for East Africa's public health resilience, economic development, and strategic autonomy in an increasingly unstable global environment.
The COVID-19 Wake-Up Call: Africa's Dependence Exposed
To understand why the Regional Capability and Capacity Network matters, it is essential to revisit the harsh lessons Africa learned during the COVID-19 pandemic — lessons that revealed dangerous dependencies and structural weaknesses that had been building for decades but became undeniable when the crisis struck.
The vaccine access crisis: When COVID-19 vaccines became available in late 2020 and early 2021, wealthy countries immediately secured the vast majority of global supply through advance purchase agreements with manufacturers in North America, Europe, and Asia. African countries, which produce virtually none of their own vaccines, were left competing for scarce remaining doses in a global market characterized by vaccine nationalism, export restrictions, and allocation mechanisms that favored countries with purchasing power and political leverage over those with greatest epidemiological need.
The result was a dramatic vaccination gap. By mid-2021, when many high-income countries had vaccinated 50-70% of their populations, most African countries had vaccinated less than 5%. The inequity was not merely statistical — it translated into preventable deaths, prolonged economic disruption, continued school closures affecting millions of children, and delayed recovery that set back development progress across the continent. The African Union's attempts to procure vaccines collectively through COVAX and direct manufacturer negotiations achieved some success but could not overcome the fundamental reality: Africa does not control its vaccine supply and therefore cannot guarantee access during global emergencies.
Beyond vaccines: the broader dependence: While vaccines received the most public attention, Africa's dependence on external suppliers extends across the entire spectrum of health products. Diagnostics used to detect infectious diseases are overwhelmingly imported. Therapeutics — the medicines used to treat COVID-19 patients and countless other conditions — are primarily manufactured outside Africa and supplied through supply chains vulnerable to disruption. Personal protective equipment (PPE) for healthcare workers comes predominantly from Asian manufacturers. Laboratory reagents and equipment necessary for disease surveillance and research are imported. Medical devices from oxygen concentrators to ventilators to imaging equipment are sourced externally.
This comprehensive dependence creates multiple vulnerabilities. During global health emergencies, African countries compete for products in markets where they have little bargaining power and limited alternatives. When supply chains are disrupted by pandemics, trade conflicts, or natural disasters, Africa experiences shortages more acutely than regions with domestic manufacturing capacity. Price volatility in global markets directly affects African health systems' ability to procure essential products. Quality control is difficult when products are manufactured thousands of miles away under regulatory frameworks that may not prioritize African consumer protection.
The capacity gap: Africa's limited manufacturing capacity reflects persistent structural challenges that the RCCN is explicitly designed to address. The continent lacks sufficient numbers of scientists, engineers, and technicians with specialized skills in biomanufacturing, pharmaceutical production, quality assurance, regulatory affairs, and supply chain management. Universities and technical training institutions have not historically aligned their curricula with the specific competencies required for vaccine and pharmaceutical manufacturing. Regulatory systems in many African countries lack the capacity, resources, and harmonization necessary to efficiently approve and oversee locally manufactured health products. Investment in biomanufacturing infrastructure has been limited due to perceived risks, small national markets, and competition from established manufacturers in other regions.
The RCCN Solution: Coordinated Regional Workforce Development
The Regional Capability and Capacity Network represents Africa CDC's strategic response to these challenges, operating on the principle that sustainable manufacturing capacity must be built on a foundation of appropriate human capital, institutional collaboration, and regional coordination.
Continental architecture with regional implementation: The RCCN operates at two levels simultaneously. At the continental level, Africa CDC provides overall strategic direction, coordinates among regional secretariats, links RCCN activities to broader African Union health security and manufacturing strategies, mobilizes resources and development partner support, and establishes standards and frameworks for capacity building across regions.
At the regional level, four secretariats have been established to operationalize RCCN priorities in specific geographic contexts: East Africa (hosted in Rwanda), West Africa (hosted in Nigeria), Southern Africa (hosted in South Africa), and North Africa (hosted in Egypt). This regional structure recognizes that Africa's 54 countries have diverse contexts, capabilities, and priorities that are better addressed through regional coordination than through one-size-fits-all continental programs.
The East Africa Secretariat's mandate: Hosted by Rwanda through Syllabi — the country's national e-learning platform and educational technology initiative under the Ministry of Education — in collaboration with the Regional Centre of Excellence for Vaccinology, Immunization and Health Supply Chain Management (RCE-VIHSCM), the Secretariat serves five countries: Rwanda, Tanzania, Uganda, Kenya, and Ethiopia. These five countries represent approximately 300 million people, diverse economic development levels, significant variation in higher education and research capacity, and different stages of pharmaceutical and biomanufacturing sector development.
The Secretariat's core functions focus on workforce development and institutional coordination: aligning academic programs with emerging industry and regulatory requirements so that universities produce graduates with skills actually needed by manufacturers and regulators; supporting curriculum reform and harmonization across the region to enable labor mobility and reduce duplication of effort across national education systems; convening technical exchanges among universities, regulators, and manufacturers to facilitate knowledge sharing, collaborative problem-solving, and partnership development; and linking national initiatives with continental strategies led by Africa CDC and the African Union to ensure regional efforts contribute to broader Pan-African objectives.
Minister Irere's Education-Centered Vision
In her keynote address at the workshop, Claudette Irere, Minister of State for Education in Rwanda, articulated a vision that positions education and skills development as the foundational pillar of Africa's manufacturing transformation:
"At the centre of this transformation is education and skills development. If we are serious about advancing vaccine manufacturing and health security, our academic and training systems must evolve."
This framing is significant because it locates the challenge not primarily in financing, infrastructure, or technology transfer — although all are important — but in human capital development and institutional capability. Minister Irere's emphasis reflects several key insights:
Manufacturing requires specialized competencies: Vaccine and pharmaceutical manufacturing is not general industrial production. It requires specialized expertise in biotechnology, molecular biology, immunology, pharmaceutical chemistry, bioprocess engineering, quality assurance and quality control, regulatory compliance, and supply chain management specific to biologics and temperature-sensitive products. These competencies are not typically covered adequately in general science, engineering, or healthcare degree programs. They require targeted curriculum development, specialized equipment and laboratories for practical training, faculty with industry experience or ongoing industry engagement, and continuous updating as technologies and regulatory standards evolve.
Education systems must be responsive and adaptive: Historically, many African universities have operated with relatively static curricula that change slowly and are not tightly linked to labor market demands or industry developments. Minister Irere's call for academic systems to "evolve" signals recognition that the traditional model — where universities define curricula based primarily on academic considerations without systematic industry input — is insufficient for emerging sectors like biomanufacturing. Instead, education systems must actively engage with industry to understand workforce needs, incorporate industry practitioners into curriculum design and teaching, create internship and practicum opportunities for students to gain real-world experience, and adapt programs quickly as industry technologies and practices change.
Regional harmonization multiplies impact: When each country develops its biomanufacturing education programs independently, several problems arise: graduates may not have portable credentials recognized across borders, limiting labor mobility; small national markets may not justify the fixed costs of specialized programs, leading to underinvestment; duplication of effort wastes scarce resources that could be better pooled; and regulatory requirements may diverge across countries, creating complexity for regional manufacturers. Harmonization — developing shared competency frameworks, mutual recognition agreements, collaborative programs across universities in multiple countries, and aligned regulatory standards — addresses these problems and enables the region to develop capacity more efficiently than individual countries working in isolation.
Why Rwanda? Strategic Positioning as Regional Hub
The selection of Kigali as the host location for the RCCN East Africa Secretariat reflects several factors that position Rwanda as an appropriate anchor for regional coordination despite being one of the smaller countries in the five-nation network.
Political commitment and governance capacity: Rwanda has demonstrated consistent political commitment to health security, education quality, and regional integration. The government's ability to provide stable policy environments, efficient administration, and follow-through on commitments makes it a reliable host for regional institutions. The country's track record of successfully hosting continental and regional bodies — including the African Union Development Agency (AUDA-NEPAD) headquarters and numerous African Union summits — demonstrates institutional capacity to manage regional coordination functions effectively.
Education sector investments and innovation: Rwanda has invested heavily in education transformation over the past decade, including curriculum reform aligned with competency-based education, expansion of STEM (Science, Technology, Engineering, Mathematics) education, development of the Syllabi digital learning platform that can support regional capacity building, establishment of centres of excellence in areas relevant to biomanufacturing (biotechnology, health sciences, engineering), and strong partnerships with international universities and technical institutions that can support workforce development programs.
The decision to anchor the Secretariat within the Ministry of Education through Syllabi — rather than housing it in a health ministry or regulatory agency — reinforces the strategic emphasis on workforce development and education system transformation as the pathway to manufacturing capacity.
Geographic and logistical advantages: Kigali's central location within East Africa provides relatively easy access for partners from Tanzania, Uganda, Kenya, and Ethiopia. The city's well-developed conference and meeting facilities, reliable ICT infrastructure, and established status as a regional hub for international organizations create enabling conditions for the convening and coordination functions the Secretariat will perform.
Biomanufacturing ambitions and investments: Rwanda is actively building domestic capacity in vaccine and pharmaceutical manufacturing through partnerships with BioNTech for mRNA vaccine production, investments in local pharmaceutical manufacturing, development of the Kigali Innovation City as a hub for biotech and health innovation, and policy frameworks supportive of private sector investment in health manufacturing. These national initiatives create synergies with the regional Secretariat's work — Rwanda can learn from regional partners while sharing its own experiences, facilities developed for national purposes can potentially serve regional training needs, and Rwanda's policy experiments can inform regional approaches.
The Three-Year Priorities: Building Foundations for Long-Term Transformation
The RCCN East Africa Secretariat has outlined four priority areas for its initial three-year operational period, each addressing critical elements of the regional capability-building challenge:
Priority 1: Deeper regional collaboration: The first priority focuses on strengthening the mechanisms and relationships that enable effective coordination across the five countries. This includes establishing regular convenings of relevant government ministries (education, health, industry, science and technology) from each country to align policies and share information; creating technical working groups bringing together faculty from universities across the region to collaborate on curriculum development, research, and knowledge exchange; building peer learning networks among regulatory agencies to harmonize standards, share inspection methodologies, and coordinate approval processes; and facilitating industry-academia-government platforms where manufacturers, universities, and policymakers can jointly identify priorities, address bottlenecks, and coordinate investments.
Deeper collaboration is essential because biomanufacturing capacity cannot be built by individual institutions or countries working alone. The specialized expertise, expensive equipment, research infrastructure, and market scale required all benefit from regional pooling of resources and coordination of efforts.
Priority 2: Strengthened institutional sustainability: For the Secretariat itself and the institutions it coordinates to function effectively over time, sustainable operational and financial models must be developed. This includes securing multi-year funding commitments from governments, development partners, and potentially industry contributions; building the Secretariat's technical staff capacity to provide high-quality coordination, technical assistance, and monitoring services; establishing monitoring and evaluation systems to track progress, identify challenges, and demonstrate impact to funders and stakeholders; and developing governance structures that ensure accountability, transparency, and inclusive decision-making involving all five member countries.
Sustainability matters because capacity building is a long-term endeavor. Training a new generation of biomanufacturing professionals, reforming university curricula, establishing regulatory frameworks, and building industry-academia partnerships take years to mature. If the Secretariat operates on short-term, unpredictable funding cycles or lacks the technical capacity to fulfill its mandate, the initiative will fail to achieve lasting impact.
Priority 3: Increased industry engagement: Academic programs and regulatory frameworks must be designed with direct input from the industries they are intended to serve and regulate. The third priority emphasizes systematic engagement with pharmaceutical and biomanufacturing companies — both existing manufacturers in the region and potential investors considering East African operations. This includes industry participation in curriculum design to ensure graduates have skills companies actually need; provision of internship, practicum, and employment opportunities for students; industry-funded research collaborations with universities on challenges relevant to biomanufacturing in African contexts; and industry feedback on regulatory frameworks to balance patient safety with efficient approval processes that do not unnecessarily delay product availability or create barriers to investment.
Industry engagement is critical because ultimately, the success of workforce development efforts will be measured by whether graduates find employment in biomanufacturing, whether companies find the talent they need, and whether regulatory systems enable rather than obstruct manufacturing development. Without systematic industry input, academic programs risk producing graduates with skills that do not match market needs, and regulatory frameworks risk being either too lax (compromising safety) or too burdensome (deterring investment).
Priority 4: Alignment with continental strategies: The regional Secretariat must ensure its activities contribute to and benefit from broader continental initiatives led by Africa CDC and the African Union. This includes aligning workforce development priorities with the African Medicines Agency's (AMA) regulatory harmonization efforts; coordinating with the Partnerships for African Vaccine Manufacturing (PAVM) initiative to ensure workforce supply matches manufacturing investment locations and timelines; contributing regional inputs to Africa CDC's continental health security strategy and pandemic preparedness planning; and learning from and sharing experiences with the three other regional RCCN secretariats (West Africa, Southern Africa, North Africa) to identify best practices and avoid duplicating efforts.
Continental alignment ensures that regional investments reinforce rather than conflict with Pan-African strategies, that resources are used efficiently without unnecessary duplication, and that East Africa benefits from lessons learned in other regions while contributing its own innovations to continental knowledge.
What Success Would Look Like: Measuring Impact
How will we know if the RCCN East Africa Secretariat succeeds? Several indicators will signal progress toward the initiative's objectives:
Workforce indicators: The number of university graduates in biomanufacturing-relevant fields should increase across the five countries, with demonstrable alignment between their competencies and industry requirements verified through employer satisfaction surveys and graduate employment rates. Universities should establish or expand specialized programs in vaccine science, bioprocess engineering, pharmaceutical manufacturing, and regulatory science. Industry should report improved ability to recruit qualified professionals locally rather than relying primarily on expatriate talent or sending employees abroad for training.
Manufacturing development indicators: The number of operational biomanufacturing facilities in East Africa should increase, with at least some facilities citing local workforce availability as a factor in location decisions. The volume and value of vaccines, therapeutics, and diagnostics produced within the region should grow. Regional facilities should progressively move up the value chain from fill-finish operations (final packaging of products manufactured elsewhere) to full end-to-end manufacturing including active pharmaceutical ingredient production.
Regulatory harmonization indicators: The five countries should demonstrate progress toward mutual recognition of regulatory approvals for regionally manufactured products, reducing the need for manufacturers to undergo separate approval processes in each country. Regulatory approval timelines should decrease as agencies build capacity and adopt risk-based, efficient review processes. Product quality incidents should remain low or decrease, demonstrating that regulatory efficiency does not come at the expense of safety.
Regional collaboration indicators: Joint academic programs, research projects, and student exchanges among universities across the five countries should increase. Industry-academia partnerships should multiply and deepen. Government policies affecting biomanufacturing should show evidence of cross-country coordination and learning rather than being developed in isolation.
Challenges on the Horizon
Despite strong commitment and thoughtful design, the RCCN East Africa will face significant challenges that will test its ability to deliver on ambitious objectives:
Financing sustainability: Workforce development and institutional coordination require sustained funding over many years. Initial enthusiasm and donor support may wane if visible results take time to materialize. Securing multi-year commitments from governments facing competing budget priorities and convincing development partners to maintain support through inevitably slow institution-building processes will be ongoing challenges.
Coordinating diverse national contexts: The five countries in the network have different political systems, regulatory frameworks, education structures, economic development levels, and priorities. Achieving genuine harmonization and coordination while respecting legitimate national differences and sovereignty will require diplomatic skill, flexibility, and patient consensus-building.
Competing with established manufacturers: Even as East Africa builds local capacity, it will compete with well-established manufacturers in India, China, Europe, and elsewhere who benefit from decades of experience, economies of scale, established distribution networks, and strong government support. Convincing customers (including African governments) to purchase from newer, smaller East African manufacturers rather than proven global suppliers will require more than just availability — it will require competitive quality, pricing, and reliability.
Brain drain: As East African universities produce more professionals with specialized biomanufacturing skills, those individuals become attractive to employers globally, particularly in high-income countries offering higher salaries and better working conditions. Retaining talent in the region will require creating attractive career opportunities, competitive compensation, and professional development pathways that can compete with international options.
Conclusion: From Dependence to Self-Reliance
The launch of the RCCN East Africa Secretariat in Kigali represents a strategic choice about Africa's future in global health security and biomanufacturing. The continent can continue its historical pattern of dependence on external suppliers, accepting the vulnerabilities that dependence creates and the limited economic benefits it provides. Or it can invest systematically in building the human capital, institutional frameworks, and regional coordination necessary to produce its own vaccines, diagnostics, therapeutics, and other health products.
Minister Irere's emphasis on education and skills development as the foundation of this transformation reflects a sophisticated understanding that manufacturing capacity is not primarily about importing technology or building factories — though both matter — but about developing people who understand the science, engineering, regulation, and business of biomanufacturing and who can continuously innovate, adapt, and improve as technologies and markets evolve.
The choice of Rwanda as the regional anchor, the focus on harmonization and regional collaboration, and the explicit three-year priorities all signal seriousness of purpose and realistic understanding of the challenges ahead. The COVID-19 pandemic exposed dangerous dependencies that cost African lives and economic wellbeing. The RCCN East Africa is Africa CDC's strategic response, betting that coordinated investment in education, workforce development, and institutional capacity can, over time, transform East Africa from a consumer dependent on external suppliers to a producer capable of meeting its own needs and competing globally.
Success is not guaranteed and will not come quickly. But the alternative — continuing dependence on supply chains and markets that have repeatedly failed Africa during crises — is unacceptable. The inaugural workshop in Kigali was more than a launch event. It was a commitment by five countries to build, together, the capabilities necessary for health security, economic opportunity, and strategic autonomy in an increasingly uncertain world.
Post a Comment